Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

NOLPAZA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/NOLPAZA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG

Approved

STANDARD

NOLPAZA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG

Krka D.D. Novo Mesto🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Oct 1, 2020
Approval ID: 272fd50c87db8fbc
Company: Krka D.D. Novo Mesto
Type: Standard

Approval Details

Approval Id: 272fd50c87db8fbc
Drug Cima Aemps Name: NOLPAZA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG
Register Number: 14135
Holder Company Name: Krka D.D. Novo Mesto
Marketing Company Name: Elam Pharma Labs S.L.
Authorization Date: 2020-10-01
Dosage Form: COMPRIMIDO GASTRORRESISTENTE
Dose: 40 MG
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Krka D.D. Novo Mesto

Active Ingredients

PANTOPRAZOL SODICO SESQUIHIDRATO

45,1 mg

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Oct 1, 2020

Approval ID

272fd50c87db8fbc

Type

Standard

Back to CIMA-AEMPS Approvals